Risk of reduced medical institution investment appetite due to reimbursement rate revisions
First written in FY2016. 12 of 13 entries say "Restated". Latest entry: FY2024-Q1.
0 other companies' latest entry also says "Restated".
- FY2024-Q1RestatedAnnual report
「During the first quarter of the current fiscal year, there were no new occurrences of the major risks that management recognises could materially affect the financial position, operating results or cash flows of the Group among the matters relating to business conditions, financial conditions and other matters described in the quarterly report, and no material changes to the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
It explains that there have been no material changes in the risk of reduced healthcare-provider investment appetite due to revisions to medical fees. - FY2021-Q3RestatedAnnual report
「During the first three quarters of the current fiscal year, there were no new occurrences of the major risks that management recognises could materially affect the filing company's financial position, operating results or cash flows among the matters relating to business conditions, financial conditions and other matters described in the quarterly report, and no material changes to the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
No material changes have been identified in the risk of reduced healthcare-provider investment appetite due to revisions to medical fees. - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no new major risks that management recognizes could have a material impact on the financial condition, operating results or cash flows of the filing company, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
No material changes have been identified in the risk of reduced healthcare-provider investment appetite due to revisions to medical fees. - FY2020-Q1RestatedAnnual report
「During the first quarter of the current fiscal year, no new business or other risks arose. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
No material changes have been identified in the risk of reduced healthcare-provider investment appetite due to revisions to medical fees. - FY2019RestatedAnnual report
「In our healthcare solutions business, if medical fees are reduced in a revision of medical fees, which is conducted once every 2 years in accordance with government policy, this could squeeze healthcare providers' earnings and reduce their appetite for investment, thereby affecting this business and its performance.」
The risk of reduced healthcare-provider investment appetite due to the once-every-2-years revision of medical fees remains. - FY2019-Q1RestatedAnnual report
「During the first quarter of the current fiscal year, no new business or other risks arose. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
No material changes have been identified in the risk of reduced healthcare-provider investment appetite due to revisions to medical fees. - FY2018RestatedAnnual report
「In our healthcare solutions business, if medical fees are reduced in a revision of medical fees, which is conducted once every 2 years in accordance with government policy, this could squeeze healthcare providers' earnings and reduce their appetite for investment, thereby affecting this business and its performance.」
The risk of reduced healthcare-provider investment appetite due to the once-every-2-years revision of medical fees remains. - FY2018-Q1RestatedAnnual report
「During the cumulative consolidated period for the first quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
No material changes have been identified in the risk of reduced healthcare-provider investment appetite due to revisions to medical fees. - FY2017RestatedAnnual report
「In our group's medical imaging business, if medical fees are reduced in a revision of medical fees, which is conducted once every 2 years in accordance with government policy, this could squeeze healthcare providers' earnings and reduce their appetite for investment, thereby affecting this business and its performance.」
The risk of reduced healthcare-provider investment appetite due to the once-every-2-years revision of medical fees remains. - FY2017-Q3RestatedAnnual report
「During the cumulative third quarter, no new business or other risks arose. In addition, there were no material changes in the business and other risks described in the securities report for the previous fiscal year.」
No material changes have been identified in the risk of reduced healthcare-provider investment appetite due to revisions to medical fees. - FY2017-Q2RestatedAnnual report
「During the cumulative second quarter, no new business or other risks arose. In addition, there were no material changes in the business and other risks described in the securities report for the previous fiscal year.」
No material changes have been identified in the risk of reduced healthcare-provider investment appetite due to revisions to medical fees. - FY2017-Q1RestatedAnnual report
「During the cumulative consolidated period for the first quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
No material changes have been identified in the risk of reduced healthcare-provider investment appetite due to revisions to medical fees. - FY2016First statedAnnual report
「In our medical imaging business, if medical fees are reduced in a revision of medical fees, which is conducted once every 2 years in accordance with government policy, this could squeeze healthcare providers' earnings and reduce their appetite for investment, thereby affecting this business and its performance.」
It identifies the possibility that a reduction in medical fees in the once-every-2-years revision of medical fees could affect the medical imaging business through healthcare providers' investment appetite.